We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PTO Grants More Reviews of Herceptin Patents After Hospira Challenges
The item has been added to your shopping cart.
PTO Grants More Reviews of Herceptin Patents After Hospira Challenges
The PTO’s Patent Trial and Appeal Board will evaluate the validity of three Genentech patents covering its blockbuster breast cancer treatment Herceptin, following petitions for inter partes review filed by Hospira.